|
DNA Phenomics is engaged in the discovery and production of genomic-based personalized medical solutions* for the region's diverse populations. In partnership with healthcare providers, university research labs and pharmaceutical companies, DNA Phenomics' impressive new technologies and genome-based diagnostic products will speed the discovery of important new medical and pharmaceutical products.
The company's discovery platform offers pharmaceutical and life science companies a powerful research tool capable of uncovering patterns in the genome associated with health factors, disease, and individual drug response.
DNA Phenomics' goal is to become a leader in the discovery, development, and sale of genomic-based diagnostic healthcare products and biotech research services throughout Asia and the Pacific.
*Personalized medicine is the prescription of specific treatments and therapeutics based on information about a patient's genetic makeup.
|